← Back to headlines
New Cystic Fibrosis Therapy Seeks Refund Approval in Poland
Vertex Pharmaceuticals has applied for refund approval for its latest drug, a new targeted therapy for specific genetic subtypes of cystic fibrosis, in Poland. The company continues to seek therapies for the condition.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
